You’re invited! The NFXF-led patient-focused drug development meeting is to be held March 3, 2021. The purpose of this meeting is to hear from YOU to help guide future drug development in Fragile X syndrome. We’re asking patients, family members, caregivers, and patient advocates to share their experiences at this meeting, and all other attendees will be listening. There will be a final report that summarizes the meeting, helping researchers design more patient-centric and effective treatment recommendations. Please join us for this amazing opportunity!